Literature DB >> 25461251

Related-to-receptor tyrosine kinase receptor regulates hematopoietic stem and progenitor sensitivity to myelosuppressive injury in mice.

Benjamin J Povinelli1, Pragya Srivastava2, Michael J Nemeth3.   

Abstract

Maintaining a careful balance between quiescence and proliferation of hematopoietic stem and progenitor cells (HSPCs) is necessary for lifelong blood formation. Previously, we demonstrated that the Wnt5a ligand inhibits HSPC proliferation through a functional interaction with a noncanonical Wnt ligand receptor termed 'related-to-receptor tyrosine kinase' (Ryk). Expression of Ryk on HSPCs in vivo is associated with a lower rate of proliferation, and, following treatment with fluorouracil (5-FU), the percentage of Ryk(+/high) HSPCs increased and the percentage of Ryk(-/low) HSPCs decreased. Based on these data, we hypothesized that one function of the Ryk receptor is to protect HSPCs from the effects of myeloablative agents. We found that Ryk expression on HSPCs is associated with lower rates of apoptosis following 5-FU and radiation. Transient inhibition of Ryk signaling in vivo resulted in increased hematopoietic-stem-cell proliferation and decreased hematopoietic-stem-cell function in bone marrow transplant assays. Furthermore, inhibition of Ryk signaling sensitized HSPCs to 5-FU treatment in association with increased levels of reactive oxygen species. Together, these results demonstrated an association between Ryk expression and survival of HSPCs following suppressive injury.
Copyright © 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25461251      PMCID: PMC5577938          DOI: 10.1016/j.exphem.2014.10.014

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  36 in total

1.  Possible involvement of oxidative stress in 5-fluorouracil-mediated myelosuppression in mice.

Authors:  Satoshi Numazawa; Kazuko Sugihara; Shota Miyake; Hirono Tomiyama; Ayako Hida; Misato Hatsuno; Masayuki Yamamoto; Takemi Yoshida
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-08-16       Impact factor: 4.080

2.  Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation.

Authors:  Michael J Nemeth; Lilia Topol; Stacie M Anderson; Yingzi Yang; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

3.  Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair.

Authors:  Anne Wilson; Elisa Laurenti; Gabriela Oser; Richard C van der Wath; William Blanco-Bose; Maike Jaworski; Sandra Offner; Cyrille F Dunant; Leonid Eshkind; Ernesto Bockamp; Pietro Lió; H Robson Macdonald; Andreas Trumpp
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

Review 4.  Quiescence regulators for hematopoietic stem cell.

Authors:  June Li
Journal:  Exp Hematol       Date:  2011-02-01       Impact factor: 3.084

5.  Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche.

Authors:  Ryohichi Sugimura; Xi C He; Aparna Venkatraman; Fumio Arai; Andrew Box; Craig Semerad; Jeffrey S Haug; Lai Peng; Xiao-Bo Zhong; Toshio Suda; Linheng Li
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

6.  Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis.

Authors:  Mary Mohrin; Emer Bourke; David Alexander; Matthew R Warr; Keegan Barry-Holson; Michelle M Le Beau; Ciaran G Morrison; Emmanuelle Passegué
Journal:  Cell Stem Cell       Date:  2010-07-08       Impact factor: 24.633

7.  Src family kinases are required for WNT5 signaling through the Derailed/RYK receptor in the Drosophila embryonic central nervous system.

Authors:  Rene R Wouda; Monique R K S Bansraj; Anja W M de Jong; Jasprina N Noordermeer; Lee G Fradkin
Journal:  Development       Date:  2008-07       Impact factor: 6.868

8.  A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche.

Authors:  Yoon-Young Jang; Saul J Sharkis
Journal:  Blood       Date:  2007-06-26       Impact factor: 22.113

9.  Wnt-Ryk signaling mediates axon growth inhibition and limits functional recovery after spinal cord injury.

Authors:  Tomohiro Miyashita; Masao Koda; Keiko Kitajo; Masashi Yamazaki; Kazuhisa Takahashi; Akira Kikuchi; Toshihide Yamashita
Journal:  J Neurotrauma       Date:  2009-07       Impact factor: 5.269

10.  Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor.

Authors:  Benjamin J Povinelli; Michael J Nemeth
Journal:  Stem Cells       Date:  2014-01       Impact factor: 6.277

View more
  3 in total

1.  Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program.

Authors:  Charu Mehta; Kirby D Johnson; Xin Gao; Irene M Ong; Koichi R Katsumura; Skye C McIver; Erik A Ranheim; Emery H Bresnick
Journal:  Cell Rep       Date:  2017-09-19       Impact factor: 9.423

Review 2.  Cellular components of the hematopoietic niche and their regulation of hematopoietic stem cell function.

Authors:  Joydeep Ghosh; Roy El Koussa; Safa F Mohamad; Jianyun Liu; Melissa A Kacena; Edward F Srour
Journal:  Curr Opin Hematol       Date:  2021-07-01       Impact factor: 3.218

3.  Ryk modulates the niche activity of mesenchymal stromal cells by fine-tuning canonical Wnt signaling.

Authors:  Seon-Yeong Jeong; Jungmook Lyu; Jin-A Kim; Il-Hoan Oh
Journal:  Exp Mol Med       Date:  2020-07-28       Impact factor: 8.718

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.